Kuhlman B, Diaz J, Simon T, Reeves K, Walker S, Atala A
NPJ Microgravity. 2024; 10(1):85.
PMID: 39143086
PMC: 11324864.
DOI: 10.1038/s41526-024-00424-1.
Morimoto T, Nakazawa T, Maeoka R, Matsuda R, Nakamura M, Nishimura F
Regen Ther. 2024; 25:367-376.
PMID: 38405180
PMC: 10891285.
DOI: 10.1016/j.reth.2024.02.002.
Morimoto T, Nakazawa T, Matsuda R, Maeoka R, Nishimura F, Nakamura M
Int J Mol Sci. 2024; 25(4).
PMID: 38397112
PMC: 10889440.
DOI: 10.3390/ijms25042435.
Morimoto T, Nakazawa T, Maeoka R, Nakagawa I, Tsujimura T, Matsuda R
Int J Mol Sci. 2023; 24(3).
PMID: 36768432
PMC: 9916747.
DOI: 10.3390/ijms24032111.
Chan I, Ewald A
J Clin Invest. 2022; 132(6).
PMID: 35289318
PMC: 8920322.
DOI: 10.1172/JCI143762.
CD8 T Lymphocyte and NK Cell Network: Circuitry in the Cytotoxic Domain of Immunity.
Uzhachenko R, Shanker A
Front Immunol. 2019; 10:1906.
PMID: 31456803
PMC: 6700470.
DOI: 10.3389/fimmu.2019.01906.
Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-specific immunosurveillance in lung cancer.
Chockley P, Chen J, Chen G, Beer D, Standiford T, Keshamouni V
J Clin Invest. 2018; 128(4):1384-1396.
PMID: 29324443
PMC: 5873856.
DOI: 10.1172/JCI97611.
A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity.
Kandarian F, Sunga G, Arango-Saenz D, Rossetti M
J Vis Exp. 2017; (126).
PMID: 28829424
PMC: 5614136.
DOI: 10.3791/56191.
Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma....
Mordoh J, Pampena M, Aris M, Blanco P, Lombardo M, von Euw E
Front Immunol. 2017; 8:625.
PMID: 28620382
PMC: 5449770.
DOI: 10.3389/fimmu.2017.00625.
Beta2-adrenoceptor stimulation suppresses TLR9-dependent IFNA1 secretion in human peripheral blood mononuclear cells.
Hilbert T, Bongartz J, Weisheit C, Knufermann P, Baumgarten G, Hoeft A
PLoS One. 2013; 8(5):e65024.
PMID: 23724117
PMC: 3665595.
DOI: 10.1371/journal.pone.0065024.
The role of natural killer cells in pulmonary immunosurveillance.
Hesker P, Krupnick A
Front Biosci (Schol Ed). 2013; 5(2):575-87.
PMID: 23277070
PMC: 4413461.
DOI: 10.2741/s391.
The relationship between the frequency of the common cold and the activities of natural killer cells.
Xu M, Muto T, Yabe T, Nagao F, Fukuwatart Y, Okumura K
Environ Health Prev Med. 2011; 4(4):212-6.
PMID: 21432487
PMC: 2723598.
DOI: 10.1007/BF02931260.
Real-time PCR method for the quantitative analysis of human T-cell receptor gamma and beta gene rearrangements.
Chain J, Joachims M, Hooker S, Laurent A, Knott-Craig C, Thompson L
J Immunol Methods. 2005; 300(1-2):12-23.
PMID: 15882867
PMC: 1828693.
DOI: 10.1016/j.jim.2005.01.016.
The detection and identification of subpopulations of circulating human lymphocytes, monocytes and neutrophils capable of effecting a mitogen-induced cell-mediated cytotoxic reaction towards erythrocytes of various species.
Cortens M, SKLAR S, Richter M
Immunology. 1980; 41(3):623-34.
PMID: 7461704
PMC: 1458145.
Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.
Auer I, Ziemer E, Sommer H
Clin Exp Immunol. 1980; 42(1):41-9.
PMID: 7460390
PMC: 1537072.
Isolation of human spontaneous killer lymphocytes by bacterial adherence.
Kleinman R, De Boer K, Teodorescu M
Clin Exp Immunol. 1980; 39(2):510-8.
PMID: 7389207
PMC: 1538050.
NK and K cell activity of human blood: differences according to sex, age, and disease.
Penschow J, Mackay I
Ann Rheum Dis. 1980; 39(1):82-6.
PMID: 7377864
PMC: 1000475.
DOI: 10.1136/ard.39.1.82.
Natural killer activity in patients with biopsy-proven liver disease.
Serdengecti S, Jones D, Holdstock G, Wright R
Clin Exp Immunol. 1981; 45(2):361-4.
PMID: 7318258
PMC: 1537378.
Effector cells in natural cytotoxicity against human bladder cancer cell lines.
Bloom E
Urol Res. 1981; 9(5):219-25.
PMID: 7303345
DOI: 10.1007/BF00256890.
The antibody-independent cytotoxic activity of normal circulating human leucocytes. I. Lysis of target cells by monocytes and neutrophils in a non-phagocytic pathway.
Banerjee D, Fernando L, SKLAR S, Richter M
Immunology. 1981; 44(1):97-107.
PMID: 7275189
PMC: 1555122.